Target intelligence / Profile preview

Ephrin-A3 (EFNA3)

Target
EFNA3
Molecular classification
Cell surface protein, Ligand, Receptor (ligand for receptor tyrosine kinases), Glycosylphosphatidylinositol (GPI)-anchored protein, Member of Ephrin-A family
01

Overview

Ephrin-A3 is a **cell surface GPI-anchored ligand** for the Eph family of receptor tyrosine kinases, which are among the largest known subfamilies of such receptors[1][2][7]. The protein is crucial for mediating cell-cell communication, especially during developmental processes like nervous system patterning and erythropoiesis. Ephrin-A3 binds promiscuously to various Eph receptors on neighboring cells, resulting in **contact-dependent, bidirectional signaling**: “forward” signaling through the Eph receptor and “reverse” signaling through ephrin[2][7]. Defects or changes in EFNA3 expression have been linked to epilepsy, autism spectrum disorder, and cancer, notably functioning in some settings as a tumor suppressor[2][6]. This protein belongs to the ephrin-A subclass, which is characterized by glycosylphosphatidylinositol anchoring, distinguishing them from transmembrane ephrin-B proteins[1][2][7].

Other names
Ephrin-A3EFL2EPLG3LERK3EHK1-LLERK-3Ehk1-LEFL-2EHK1 ligandEPH-related receptor tyrosine kinase ligand 3ligand of eph-related kinase 3
02

Mechanism of action

Binding to Eph receptor tyrosine kinases, activating bidirectional signaling pathways affecting cell behavior[2][7].

03

Biological functions

Cell signalingSignal transductionCell migrationCell adhesionAxon guidanceDevelopmental regulation (notably in nervous system and erythropoiesis)Bidirectional signaling (forward and reverse)
04

Disease associations

Cancer (including tumor suppression in certain cancers)EpilepsyAutism spectrum disorderOther neurological and developmental disorders
05

Safety considerations

Potential developmental effects if targeted due to role in tissue patterningLimited clinical targeting data; risks in nervous system development and function are plausible but not established

Beyond the preview

Go deeper on Ephrin-A3 (EFNA3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ephrin-A3 (EFNA3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call